FOXP3 and non-small cell lung carcinoma: These investigations propose that FOXP3 functions as a co-activator to facilitate the Wnt-β-catenin signaling pathway and induce epithelial-mesenchymal transition, thereby promoting tumor growth and metastasis in NSCLC (16, 17).